EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation

Tobias Binder iD, Johannes Hartig iD, Lennart Sitzmann, Chi Wang Ip iD, Philipp Capetian, Florian Lange iD, Martin Reich iD, Christine Daniels, Jens Volkmann iD

Movement Disorders Clinical Practice · 08.10.2026

DOI: 10.1002/mdc3.70831 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 08.10.2026. Verfasst von Tobias Binder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Dopamine dysregulation syndrome (DDS) is a challenging complication of dopaminergic therapy in Parkinson's disease and can persist despite subthalamic deep brain stimulation (STN‐DBS). We evaluated a temporary bridging concept in which oral dopaminergic medication was replaced by continuous subcutaneous apomorphine infusion while maintaining DBS. Cases Six patients with STN‐DBS and DDS were temporarily transitioned from oral dopaminergic medication to continuous subcutaneous apomorphine infusion. Treatment success was defined as reduction of DDS below a predefined threshold (

Schlagwörter

Stichwörter der Autor:innen

advanced Parkinson's diseaseapomorphinedeep brain stimulationdopamine dysregulation syndrometreatment

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.

ORCID-Profile: Tobias Binder, Johannes Hartig, Chi Wang Ip, Florian Lange, Martin Reich, Jens Volkmann

Zitieren

APA

Binder, T., Hartig, J., Sitzmann, L., Ip, C. W., Capetian, P., Lange, F., Reich, M., Daniels, C., & Volkmann, J. (2026). Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70831

Vancouver

Binder T, Hartig J, Sitzmann L, Ip CW, Capetian P, Lange F, et al. Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70831

BibTeX
@article{Binder2026,
  author = {Binder, Tobias and Hartig, Johannes and Sitzmann, Lennart and Ip, Chi Wang and Capetian, Philipp and Lange, Florian and Reich, Martin and Daniels, Christine and Volkmann, Jens},
  title = {Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70831}
}
Kostenlos starten →